INTEGRATE CONSORTIUM LAUNCHES NEW SITE TO SUPPORT LASSA FEVER TREATMENT AND ONGOING CLINICAL TRIAL
The INTEGRATE Consortium has opened the third-largest Lassa fever treatment center and new research site in Nigeria at the Abubakar […]
News
INTEGRATE Advances Lassa Fever Research with Phase 2 of ARN-75039 Trial in Nigeria
Lassa fever, which remains endemic in West Africa, typically surges during the dry season from December to April every year.
INTEGRATE Advances Lassa Fever Research with Phase 2 of ARN-75039 Trial in Nigeria Read More »
Advancing Lassa Fever Research: INTEGRATE features at the 2025 International Conference in Abidjan
Members of the INTEGRATE consortium shared key scientific insights and presented updates on the clinical trial’s progress during the 2nd
INTEGRATE CONSORTIUM BUILDS STAFF CAPACITY TO SUPPORT ONGOING CLINICAL TRIAL
AS INCLUSIONS FOR ITS CLINICAL TRIAL FOR A NEW LASSA FEVER TREATMENT PROGRESS, THE INTEGRATE CONSORTIUM CONTINUES TO STRENGTHEN STAFF
INTEGRATE CONSORTIUM BUILDS STAFF CAPACITY TO SUPPORT ONGOING CLINICAL TRIAL Read More »
Revolutionary INTEGRATE clinical trial seeking new Lassa fever treatment starts patient inclusions
In May 2025, the INTEGRATE clinical trial officially started first patient inclusions at one of West Africa’s leading Lassa Fever